Danaher Expands Diagnostics Offerings Via $338 Mil. IRIS Acquisition

Firm will combine IRIS International with its Beckman Coulter diagnostics unit. Deal adds leading worldwide provider of automated urine microscopy and chemistry systems, including IRIS’ fully-automated iQ bench-top analyzer for urine microscopy.

Danaher Corp. will expand its in vitro diagnostics offerings through its acquisition of urinalysis device maker IRIS International Inc.for $338 million under a definitive agreement announced Sept. 17.

IRIS’ in vitro diagnostic (IVD) offerings are used to analyze the chemistry and morphology of cells and sediments in body...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Deals

More from Business